Incidence of Ventilator-Associated Pneumonia in Critically Ill Children Undergoing Mechanical Ventilation in Pediatric Intensive Care Unit

Ali Amanati, Abdollah Karimi, Alireza Fahimzad, Ahmad Reza Shamshiri, Fatemeh Fallah, Alireza Mahdavi, Mahshid Talebian, Ali Amanati, Abdollah Karimi, Alireza Fahimzad, Ahmad Reza Shamshiri, Fatemeh Fallah, Alireza Mahdavi, Mahshid Talebian

Abstract

Background: Among hospital-acquired infections (HAIs) in children, ventilator-associated pneumonia (VAP) is the most common after blood stream infection (BSI). VAP can prolong length of ventilation and hospitalization, increase mortality rate, and directly change a patient's outcome in Pediatric Intensive Care Units (PICU).

Objectives: The research on VAP in children is limited, especially in Iran; therefore, the identification of VAP incidence and mortality rate will be important for both clinical and epidemiological implications.

Materials and methods: Mechanically ventilated pediatric patients were assessed for development of VAP during hospital course on the basis of clinical, laboratory and imaging criteria. We matched VAP group with control group for assessment of VAP related mortality in the critically ill ventilated children.

Results: VAP developed in 22.9% of critically ill children undergoing mechanical ventilation. Early VAP and late VAP were found in 19.3% and 8.4% of VAP cases, respectively. Among the known VAP risk factors that were investigated, immunodeficiency was significantly greater in the VAP group (p = 0.014). No significant differences were found between the two groups regarding use of corticosteroids, antibiotics, PH (potential of hydrogen) modifying agents (such as ranitidine or pantoprazole), presence of nasogastric tube and total or partial parenteral nutrition administration. A substantial number of patients in the VAP group had more than four risk factors for development of VAP, compared to those without VAP (p = 0.087). Mortality rate was not statistically different between the VAP and control groups (p = 0.477).

Conclusion: VAP is still one of the major causes of mortality in PICUs. It is found that altered immune status is a significant risk factor for acquiring VAP. Also, occurrence of VAP was high in the first week after admission in PICU.

Keywords: incidence; mortality; pediatric intensive care units; pneumonia; ventilator-associated.

Conflict of interest statement

The authors do not have any financial or other relationships which could be regarded as a conflict of interest.

References

    1. Becerra M.R., Tantaleán J.A., Suárez V.J., Alvarado M.C., Candela J.L., Urcia F.C. Epidemiologic surveillance of nosocomial infections in a Pediatric Intensive Care Unit of a developing country. BMC Pediatrics. 2010;10:66. doi: 10.1186/1471-2431-10-66.
    1. Gauvin F., Dassa C., Chaïbou M., Proulx F., Farrell C.A., Lacroix J. Ventilator-associated pneumonia in intubated children: Comparison of different diagnostic methods. Pediatr. Crit Care Med. 2003;7:437–443. doi: 10.1097/01.PCC.0000090290.53959.F4.
    1. Raymond J., Aujard Y. Nosocomial Infections in Pediatric Patients: A European, Multicenter Prospective Study. Infect. Control Hosp. Epidemiol. 2000;21:260–263. doi: 10.1086/501755.
    1. Patria M.F., Chidini G., Ughi L., Montani C., Prandi E., Galeone C., Calderini E., Esposito S. Ventilator-associated pneumonia in an Italian pediatric intensive care unit: A prospective study. World J. Pediatr. 2013;9:365–368. doi: 10.1007/s12519-013-0444-y.
    1. Aelami M.H., Lotfi M., Zingg W. Ventilator-associated pneumonia in neonates, infants and children. Antimicrob. Resist. Infect. Control. 2014;3:30. doi: 10.1186/2047-2994-3-30.
    1. Grohskopf L.A., Sinkowitz-Cochran R.L., Garrett D.O., Sohn A.H., Levine G.L., Siegel J.D., Stover B.H., Jarvis W.R., Pediatric Prevention Network A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J. Pediatr. 2002;140:432–438. doi: 10.1067/mpd.2002.122499.
    1. Kepenekli E., Soysal A., Yalindag-Ozturk N., Ozgur O., Ozcan I., Devrim I., Akar S., Bakir M., Turkish PICU-HCAI Study Group A national point-prevalence survey of pediatric intensive care unit-acquired, healthcare-associated infections in Turkey. Jpn. J. Infect. Dis. 2015;68:381–386. doi: 10.7883/yoken.JJID.2014.385.
    1. Dalmora C.H., Deutschendorf C., Nagel F., Dos Santos R.P., Lisboa T. Defining ventilator-associated pneumonia: A (de) construction concept. Rev. Bras. Ter. Intensiva. 2013;25:81–86. doi: 10.5935/0103-507X.20130017.
    1. Lachman P., Yuen S. Using care bundles to prevent infection in neonatal and paediatric ICUs. Curr. Opin. Infect. Dis. 2009;22:224–228. doi: 10.1097/QCO.0b013e3283297b68.
    1. Solouki M., Mar’ashian S.M., Koochak M., Nasiri A., Mokhtari M., Amirpour A. Ventilator-associated pneumonia among ICU patients receiving mechanical ventilation and prophylaxis of gastrointestinal bleeding. Arch. Clin. Infect. Dis. 2009;4:177–180.
    1. Afjeh S.A., Sabzehei M.K., Karimi A., Shiva F., Shamshiri A.R. Surveillance of ventilator-associated pneumonia in a neonatal intensive care unit: Characteristics, risk factors, and outcome. Arch. Iran. Med. 2012;15:567–571.
    1. Bilan N., Habibi P. Does Re-intubation Increased Risk of Ventilator-Associated Pneumonia (VAP) in Pediatric Intensive Care Unit Patients? Int. J. Pediatr. 2015;3:411–415.
    1. Foglia E., Meier M.D., Elward A. Ventilator-Associated Pneumonia in Neonatal and Pediatric Intensive Care Unit Patients. Clin. Microbiol. Rev. 2007;20:409–425. doi: 10.1128/CMR.00041-06.
    1. Koenig S.M., Truwit J.D. Ventilator-associated pneumonia: Diagnosis, treatment, and prevention. Clin. Microbiol. Rev. 2006;19:637–657. doi: 10.1128/CMR.00051-05.
    1. Centers for Disease Control and Prevention, Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event. [(accessed on 15 March 2017)];2016 Available online: .
    1. Heyland D.K., Cook D.J., Griffith L., Keenan S.P., Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am. J. Respir. Crit. Care. Med. 1999;159:1249–1256. doi: 10.1164/ajrccm.159.4.9807050.
    1. Park D.R. The microbiology of ventilator-associated pneumonia. Respir. Care. 2005;50:742–765.
    1. Szklo M., Nieto F.J., Miller D. Epidemiology: Beyond the basics. Am. J. Epidemiol. 2001;153:821–822. doi: 10.1093/aje/153.8.821.
    1. Vincent J.L., editor. Annual Update in Intensive Care and Emergency Medicine 2015. Springer Science & Business Media; London, UK: 2015.
    1. Askarian M., Yadollahi M., Assadian O. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran. J. Infect. Public Health. 2012;5:169–176. doi: 10.1016/j.jiph.2011.12.004.
    1. Abramczyk M.L., Carvalho W.B., Carvalho E.S., Medeiros E.A.S. Nosocomial infection in a pediatric intensive care unit in a developing country. Braz. J. Infect. Dis. 2003;7:375–380. doi: 10.1590/S1413-86702003000600004.
    1. Asl H.M., Nateghian A. Epidemiology of Nosocomial Infections in a Pediatric Intensive Care Unit (PICU) Arch. Clin. Infect. Dis. 2009;4:83–86.
    1. El-Kholy A., Saied T., Gaber M., Younan M.A., Haleim M.M., El-Sayed H., El-Karaksy H., Bazara’a H., Talaat M. Device-associated nosocomial infection rates in intensive care units at Cairo University hospitals: First step toward initiating surveillance programs in a resource-limited country. Am. J. Infect. Control. 2012;40:e216–e220. doi: 10.1016/j.ajic.2011.12.010.
    1. Awasthi S., Tahazzul M., Ambast A., Govil Y.C., Jain A. Longer duration of mechanical ventilation was found to be associated with ventilator-associated pneumonia in children aged 1 month to 12 years in India. J. Clin. Epidemiol. 2013;66:62–66. doi: 10.1016/j.jclinepi.2012.06.006.
    1. Jordan García I., Arriourtúa A.B., Torre J.A., Antón J.G., Vicente J.C., González C.T. A national multicentre study on nosocomial infections in PICU. An. Pediatr. (Barc.) 2014;80:28–33. doi: 10.1016/j.anpedi.2010.09.010.
    1. Hunter J.D. Ventilator associated pneumonia. BMJ. 2012;344:e3325. doi: 10.1136/bmj.e3325.
    1. Kalanuria A.A., Zai W., Mirski M. Ventilator-associated pneumonia in the ICU. Crit. Care. 2014;18:208. doi: 10.1186/cc13775.
    1. Bonten M.J., Kollef M.H., Hall J.B. Risk Factors for Ventilator-Associated Pneumonia: From Epidemiology to Patient Management. Clin. Infect. Dis. 2004;38:1141–1149. doi: 10.1086/383039.
    1. Cooper V.B., Haut C. Preventing ventilator-associated pneumonia in children: An evidence-based protocol. Crit. Care Nurse. 2013;33:21–29. doi: 10.4037/ccn2013204.
    1. Bigham M.T., Amato R., Bondurrant P., Fridriksson J., Krawczeski C.D., Raake J., Ryckman S., Schwartz S., Shaw J., Wells D., Brilli R.J. Ventilator-Associated Pneumonia in the Pediatric Intensive Care Unit: Characterizing the Problem and Implementing a Sustainable Solution. J. Pediatr. 2008;154:582–587.e2. doi: 10.1016/j.jpeds.2008.10.019.
    1. Morehead R.S., Pinto S.J. Ventilator-associated pneumonia. Arch. Intern. Med. 2000;160:1926–1936. doi: 10.1001/archinte.160.13.1926.
    1. Klompas M. Ventilator-associated pneumonia: Is zero possible? Clin. Infect. Dis. 2010;51:1123–1126. doi: 10.1086/656738.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren